期刊文献+

错配修复蛋白表达缺失与结直肠癌病理特征及预后的关系

Relationship Between the Loss of Mismatch Repair Protein Expression and the Pathological Feature and Prognosis of Colorectal Cancer
下载PDF
导出
摘要 目的探讨错配修复蛋白的表达状态与结直肠癌病理特征和预后的关系。方法纳入于2016年9月-2022年9月在潮州市人民医院诊治的190例临床及病理资料完整的结直肠癌患者进行分析。通过免疫组化方法检测病理标本中MLH1、MSH2、MSH6和PMS2的表达状态,其中有一个表达缺失则为dMMR组,全部均有表达则分为pMMR组。分析两组患者病理特征及预后情况。结果错配修复蛋白总缺失率为21.58%。两组患者的肿瘤大小、部位、淋巴结转移、肿瘤病理分期与错配修复蛋白表达状态具有相关性(P<0.05),而肿瘤组织学类型、肿瘤分化程度、神经和/或脉管侵犯与错配修复蛋白表达状态不具相关性(P>0.05)。Kaplan-Meier分析显示,dMMR组患者无病生存时间和总生存时间均优于pMMR组患者,差异有统计学意义(P<0.05)。结论错配修复蛋白表达状态与结直肠癌的肿瘤大小、部位、淋巴结转移、肿瘤病理分期有密切关系,同时错配修复蛋白缺失患者的无病生存时间和总生存时间也较长,提示预后较好。 Objective To investigate the relationship between the expression of mismatch repair protein and the pathological characteristics and prognosis of colorectal cancer.Methods A total of 190 patients with colorectal cancer with complete clinical and pathological data who were treated in People’s Hospital of Chaozhou City from September 2016 to September 2022 were included in the analysis.The expression of MLH1,MSH2,MSH6 and PMS2 in pathological specimens was detected by immunohistochemistry.One of the expression deletions was dMMR group,and all of them were divided into pMMR group.The pathological characteristics and prognosis of the two groups were analyzed.Results The total deletion rate of mismatch repair protein was 21.58%.The tumor size,location,lymph node metastasis,tumor pathological stage of the two groups were correlated with the expression of mismatch repair protein(P<0.05),while there was no correlation between the expression of mismatch repair protein and the histological type of tumor,the degree of tumor differentiation,nerve and/or vascular invasion(P>0.05).Kaplan-Meier analysis showed that the disease-free survival time and overall survival time of patients in the dMMR group were better than those in the pMMR group,and the difference was statistically significant(P<0.05).Conclusion The expression of mismatch repair protein is closely related to the tumor size,location,lymph node metastasis and pathological stage of colorectal cancer.At the same time,the disease-free survival time and total survival time of patients with mismatch repair protein deletion are also longer,suggesting a better prognosis.
作者 李东松 陈娉珊 蔡泰楠 蔡泽华 丁玉芝 童昊 LI Dong-song;CHEN Ping-shan;CAI Tai-nan;CAI Ze-hua;DING Yu-zhi;TONG Hao(Department of Hepatobiliary Surgery,People's Hospital of Chaozhou City,Chaozhou 521011,Guangdong,China;Department of Pathology,People's Hospital of Chaozhou City,Chaozhou 521011,Guangdong,China;Department of Gastrointestinal Surgery,People's Hospital of Chaozhou City,Chaozhou 521011,Guangdong,China)
出处 《医学信息》 2024年第8期99-103,共5页 Journal of Medical Information
基金 潮州市科技计划项目(编号:2021ZC15)。
关键词 错配修复蛋白 结直肠癌 病理特征 预后 Mismatch repair protein Colorectal cancer Pathological feature Prognosis
  • 相关文献

参考文献16

二级参考文献63

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2Sinicrope FA,Mahoney MR,Smyrk TC.肿瘤部位或决定结肠癌DNA错配修复功能缺陷的预后影响[J].中华结直肠疾病电子杂志,2013,2(4):208-208. 被引量:29
  • 3Ryota Nakanishi,Jun Harada,Munkhbold Tuul,Yan Zhao,Koji Ando,Hiroshi Saeki,Eiji Oki,Takefumi Ohga,Hiroyuki Kitao,Yoshihiro Kakeji,Yoshihiko Maehara.Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer[J].International Journal of Clinical Oncology.2013(6) 被引量:2
  • 4Hyoung Ran Kim,Hee Cheol Kim,Hae-Ran Yun,Seok Hyung Kim,Cheol Keun Park,Yong Beom Cho,Seong Hyeon Yun,Woo Yong Lee,Ho-Kyung Chun.An Alternative Pathway in Colorectal Carcinogenesis Based on the Mismatch Repair System and p53 Expression in Korean Patients with Sporadic Colorectal Cancer[J].Annals of Surgical Oncology.2013(12) 被引量:1
  • 5Paul Lochhead,Aya Kuchiba,Yu Imamura,Xiaoyun Liao,Mai Yamauchi,Reiko Nishihara,Zhi Rong Qian,Teppei Morikawa,Jeanne Shen,Jeffrey A. Meyerhardt,Charles S. Fuchs,Shuji Ogino.Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication[J].JNCI Journal of the National Cancer Institute.2013(15) 被引量:3
  • 6Marjolijn J. L. Ligtenberg,Roland P. Kuiper,Ad Geurts van Kessel,Nicoline Hoogerbrugge.EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients[J].Familial Cancer.2013(2) 被引量:1
  • 7Sae‐Won Han,Hyun‐Jung Lee,Jeong Mo Bae,Nam‐Yun Cho,Kyung‐Hun Lee,Tae‐Yong Kim,Do‐Youn Oh,Seock‐Ah Im,Yung‐Jue Bang,Seung‐Yong Jeong,Kyu Joo Park,Jae‐Gahb Park,Gyeong Hoon Kang,Tae‐You Kim.Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer[J].Int J Cancer.2012(9) 被引量:2
  • 8Li-Ling Hsieh,Tze-Kiong Er,Chih-Chieh Chen,Jan-Sing Hsieh,Jan-Gowth Chang,Ta-Chih Liu.Characteristics and prevalence of KRAS , BRAF , and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwan Residents population[J].Clinica Chimica Acta (-).2012(19-20) 被引量:1
  • 9Ye-Young Rhee,Mi Kim,Jeong Bae,Jae Koh,Nam-Yun Cho,Yong-Sung Juhnn,Donguk Kim,Gyeong Kang.Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level[J].Annals of Surgical Oncology.2012(11) 被引量:2
  • 10Sung Pil Hong,Byung So Min,Tae Il Kim,Jae Hee Cheon,Nam Kyu Kim,Hoguen Kim,Won Ho Kim.The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer[J].European Journal of Cancer.2011(8) 被引量:3

共引文献277

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部